جستجوی استاد راهنمای دانشگاهی

Staffan Kjelleberg is a Distinguished University Professor at Nanyang Technological University (NTU), Singapore, and Director of the Singapore National Biofilm Consortium (SNBC) and Singapore Centre for Environmental Life Sciences Engineering (SCELSE). He holds previous positions as Scientia Professor at the University of New South Wales (UNSW), Australia, and has led major research initiatives globally. His academic career spans over four decades, with roles including Head of School at UNSW and Professorships at the University of Gothenburg, Sweden. Education: BSc (Chemistry and Biology, 1975), PhD (Microbiology, 1981), and Docent (Microbiology, 1983) from the University of Gothenburg. He has authored over 384 journal papers with significant citations, reflecting his leadership in microbial biofilm research. Research focuses on microbial biofilms and microbiomes, addressing environmental sustainability, public health, and industrial applications. He employs an interdisciplinary approach to study biofilm community dynamics, matrix properties, and translational technologies for biofilm control. Key contributions include discoveries on quorum sensing inhibitors, biofilm dispersal mechanisms, and eDNA roles in biofilm structure. Honours include Fellowships from the Australian and American Academies of Microbiology, Web of Science Highly Cited Researcher status, and Editor roles for 15 international journals. He leads major programs like the Marine Climate Change Science initiative and has co-directed global research centers such as the Centre for Marine Bio-Innovation. Advising and grants: While specific student names are not listed, his extensive leadership in research programs indicates mentorship of numerous scholars. His work bridges fundamental and applied microbiology, impacting environmental and biomedical fields. Labs/Teams: Directs SCELSE and SNBC, co-founded the Centre for Marine Bio-Innovation, and collaborates internationally on biofilm and microbiome research.

• Microbial Biofilms
• Environmental Microbiology
• Antibiofilm Drug Development
• +۴ مورد دیگر

Subash Jonnalagadda, Ph.D., is a Professor and Department Head of Chemistry & Biochemistry at Rowan University's College of Science & Mathematics, also affiliated with the Biological & Biomedical Sciences program. He holds a B.S. from Pondicherry University, M.S. from University of Hyderabad, and Ph.D. in Organic Chemistry from Purdue University, with postdoctoral training at University of Pennsylvania and University of Minnesota. Recipient of Rowan University's Wall of Fame Teaching Award (2013, 2016) Eli Lilly International Graduate Scholar (2000-2005) Research focuses on: Medicinal Chemistry: Developing boron-based small molecules (e.g., benzoboroxoles) and betulinic acid derivatives as anti-cancer agents Biomass Valorization: Converting cellulose into chemicals like hydroxymethylfurfural for bio-based polymers Publications emphasize anti-cancer drug design, nanocarrier systems, and enzyme inhibition strategies. Advised over 50 graduate/undergraduate students, many progressing to academic and pharmaceutical careers. Collaborates with Rowan School of Osteopathic Medicine on Alzheimer's drug candidates.

• Medicinal Chemistry
• Organic Chemistry
• Drug Development
• +۴ مورد دیگر

Johnny Powell is a Professor in the Department of Physics at Reed College, with a focus on astrophysics and computational physics. He leads research projects involving N-body simulations of galactic dynamics, supernovae explosions, and cosmological studies through the AGORA project. His work bridges theoretical astrophysics and experimental biophysics, with publications on DNA hydration, spectroscopy, and molecular biophysics. Primary affiliation: Reed College Physics Department Key research areas: Galactic dynamics, N-body simulations, DNA hydration, Raman/FTIR spectroscopy Professor Powell mentors thesis students in astrophysics, including work on barred galaxies, galactic bars, and cosmological simulations. His recent projects involve collaborations with institutions like the Max-Planck Institute for Solid State Research and Arizona State University's Lindsay Laboratory. Scientific grants include National Science Foundation (NSF) XSEDE awards for computational resources to study galactic bar simulations and cosmological zoom-in projects. His interdisciplinary research spans astrophysics and biophysics, with publications in journals like Biochemistry, Nucleic Acids Research, and Physical Review E. NSF Grant TG-AST150068: N-body simulations of galactic bars (50,000 SUs, 500GB) NSF Grant TG-AST150068: Buckling instability in galactic bars (25,000 SUs, 500GB) Outside academia, Powell is an avid birdwatcher with extensive field experience in Oregon, Brazil, Peru, and other global locations. He served on the Board of Directors of the Audubon Society of Portland (1998–2002) and has contributed to ornithological data via eBird. His educational collaborations include work with Stuart Lindsay at Arizona State University and Ludwig Genzel at the Max-Planck Institute.

• Astrophysics
• Galactic Dynamics
• Computational Physics
• +۳ مورد دیگر

Professor John Barrow is a Professor of Biochemistry & Molecular Biology at the University of Aberdeen, where he also serves as Dean for Employability and Entrepreneurship since 2020. He is affiliated with the School of Medicine, Medical Sciences and Nutrition, based at the Institute of Medical Sciences on the Foresterhill Campus with office address at Ashgrove Road West, AB25 2ZD. Barrow earned his academic qualifications entirely from the University of Aberdeen: a BSc(Hons) in Biochemistry (2002), PhD in Molecular Biology (2005), and PGCert in Higher Education (2011). He was awarded Senior Fellow status with the Higher Education Academy in 2015. His academic career at Aberdeen has progressed from Postdoctoral research scientist (2005-2009), through Teaching Fellow (2009-2013) and Senior Teaching Fellow (2013-2015), to Senior Lecturer (Scholarship) (2015-2021), before becoming Professor in 2021. Professor Barrow's research primarily focuses on innovative approaches to biochemistry education, with particular emphasis on virtual reality and immersive learning technologies. His work bridges traditional biochemical knowledge with cutting-edge educational methodologies, creating engaging learning experiences for students. He has pioneered the use of virtual reality for teaching complex biochemical concepts such as the citric acid cycle and molecular structures. Additionally, his research extends to graduate attributes development, employability skills, and entrepreneurship education, reflecting his dual role as both educator and Dean for Employability and Entrepreneurship. Analysis of his recent publications reveals a strong trend toward educational technology and innovative teaching methods, particularly virtual and augmented reality applications in biochemistry education. His work spans molecular biology education, skills development, and the integration of enterprise and entrepreneurship into the academic curriculum. While his earlier career included more traditional molecular biology research on topics like gene promoters and receptor pathways, his recent focus has shifted predominantly toward educational innovation. His professional recognition includes: Senior Fellow of the Higher Education Academy (2015) As Dean for Employability and Entrepreneurship, Professor Barrow oversees initiatives that connect academic learning with real-world applications, including the ABDN Grad Challenge and Hack 2040 ideathon events. His work focuses on developing students' enterprise skills and preparing them for diverse career paths. He has been instrumental in creating programs like the Employability Boost Award, designed to enhance students' career readiness through structured skill development. Professor Barrow is actively involved in curriculum development at the University of Aberdeen, particularly in transforming and embedding graduate attributes across programs. His leadership extends to external examiner roles for institutions in Pakistan and reviewing for major academic publishers and journals. His innovative approach to education has positioned him as a leader in educational technology within the medical and biochemical sciences.

• Biochemistry
• Molecular Biology
• Virtual Reality Education
• +۳ مورد دیگر

Mikhail Gelfand is a Full Professor and Director of the Center for Molecular and Cellular Biology at Skolkovo Institute of Science and Technology (Skoltech), where he also serves as Vice President for Biomedical Research. His distinguished career spans multiple prestigious institutions including Lomonosov Moscow State University and the Higher School of Economics. His educational background includes: 1985: MSc in mathematics (functional analysis) 1993: PhD in physics-mathematics (biophysics) 1998: DSc in biology (molecular biology) 2007: full professor (bioinformatics) Professor Gelfand's research focuses on molecular evolution, comparative genomics, systems biology, and metagenomics. His work examines eukaryotic processes including alternative splicing, mRNA editing, and chromatin structure, as well as bacterial genome evolution and transcription regulation. His lab combines data on three-dimensional chromatin structure, epigenetic states, and gene expression to obtain an integrated view of genome functioning across diverse organisms from humans to amoebae. One major research direction focuses on the evolution of transcript splicing and editing, while comparative analysis of bacterial genomes yields functional annotations of novel enzymes, transporters, and transcription factors. His recent publications demonstrate a strong focus on RNA editing in cephalopods, bacterial genome analysis, and computational approaches to understanding chromatin structure. The work spans molecular biology, evolutionary biology, and bioinformatics, with particular emphasis on how RNA editing contributes to adaptation and molecular evolution across metazoans. His research shows how edited adenines are more frequently substituted with guanine in evolution than their unedited counterparts, suggesting RNA editing may enhance adaptation. His notable awards include: The President of Russian Federation's Award for Young Doctors of Science (2000) The "Best Scientist of the Russian Academy of Sciences" award (2004) A. A. Baev Prize in Genomics and Genoinformatics (2007) Member of Academia Europaea (2010) As Director of the Center for Molecular and Cellular Biology, Professor Gelfand leads a research group that combines computational and experimental approaches to study genome function and evolution. His lab's work has significant implications for understanding molecular mechanisms of evolution and adaptation across diverse biological systems, from bacteria to complex eukaryotes. His research on metagenomics extends to practical applications in areas including coral disease, aphids, and oil wells.

• molecular evolution
• comparative genomics
• systems biology
• +۷ مورد دیگر

Professor Tracy Bryan is a Professor in the Faculty of Medicine and Health at the University of Sydney and serves as Unit Head of the Cell Biology Unit at the Children's Medical Research Institute (CMRI). She holds a Bachelor of Science from Macquarie University and a PhD from the CMRI, where her groundbreaking research identified the ALT (Alternative Lengthening of Telomeres) mechanism in cancer cells. After postdoctoral work with Nobel Laureate Tom Cech at the University of Colorado, she returned to Australia in 2001 to establish her research group at CMRI. Her research focuses on telomerase biology, particularly its role in cancer progression and bone marrow failure syndromes. Key themes include understanding telomerase mechanisms, developing inhibitors for cancer therapy, and investigating telomere biology disorders. Her work integrates biochemical and cell-based approaches, supported by grants from NHMRC, Viertel Foundation, and Cancer Council NSW. Recent publications highlight advancements in telomerase-substrate interactions, i-motif DNA structures, and the interplay between telomere maintenance and DNA damage responses. Major grants include NHMRC Ideas Grants targeting telomere-related bone marrow failure and ARC Discovery Projects exploring DNA replication-telomere links. Bryan’s research group collaborates internationally, contributing to translational studies in oncology and regenerative medicine. Her lab’s work is detailed at CMRI’s Cell Biology Team page, with ongoing projects focused on telomerase inhibition strategies and molecular mechanisms of telomere dysfunction.

• Cancer Biology
• Biochemistry
• Telomere Biology
• +۴ مورد دیگر

Daniela Rhodes is Professor at the School of Biological Sciences at Nanyang Technological University (since 2011) and Professor at the Lee Kong Chian School of Medicine (since 2012), where she also serves as Director of the Nanyang Institute of Structural Biology (since 2014). Previously, she spent her entire scientific career at the MRC Laboratory of Molecular Biology in Cambridge, UK, rising from Group Leader (1983) to Tenure (1987) to Full Professor (1994), and serving as Director of Studies (2003-2006). Her research focuses on the structure and function of chromatin, nucleic acids, and chromosome biology. Rhodes' work has significantly advanced our understanding of chromatin fiber organization, histone modifications, and telomere structure. Her laboratory has pioneered structural approaches to studying nucleosome organization and its implications for gene regulation and DNA packaging. Her scientific contributions have been recognized through election to prestigious academies and fellowships, including Member of Academia Europaea (2011), Fellow of the Royal Society (2007), EMBO Member (1996), and Official Fellow of Clare Hall, Cambridge (1992). Her publications primarily focus on chromatin structure, histone modifications, and nucleosome organization, with significant contributions to understanding how chromatin architecture influences gene expression and DNA function. Elected member of Academia Europaea (2011) Fellow of the Royal Society (FRS) (2007) Elected member of EMBO (1996) Official Fellow of Clare Hall, Cambridge Rhodes has extensive experience evaluating research grants for major international funding bodies including the UK Royal Society, US National Institutes of Health, European Research Council, Human Frontiers of Science Programme, and EMBO, which she has chaired since 2009. She has also served as Visiting Professor at La Sapienza University in Rome and Rockefeller University in New York. As Director of the Nanyang Institute of Structural Biology, she leads a research team focused on advancing structural approaches to understanding biomolecular complexes, particularly in the areas of chromatin organization and nucleic acid-protein interactions. Her work bridges traditional biochemistry with cutting-edge structural methodologies to address fundamental questions in molecular biology.

• Nucleic acids
• Chromosome biology
• Structure and function of chromatin
• +۲ مورد دیگر

Elizabeth T Bartom, PhD is an Associate Professor in the Department of Biochemistry and Molecular Genetics at the Feinberg School of Medicine, Northwestern University. She is affiliated with the Simpson Querrey Institute for Epigenetics, Center for Genetic Medicine, and Robert H. Lurie Comprehensive Cancer Center. PhD: Cold Spring Harbor Laboratory (2004) Postdoctoral Fellow: Harvard University and Broad Institute (2006–2010) Her research focuses on chromatin organization , transcriptional regulation , and genomic integrity in cancer and immunobiology. Recent work explores 3D genome effects in bladder cancer and pediatric brain tumors, lipid metabolism in breast cancer, and novel genomic labeling techniques. R50 Research Specialist Award, National Cancer Institute (2023) Outstanding Teacher Award, Feinberg School of Medicine (2021) Dean’s Teaching Award, Driskill Graduate Program (2019) She is a member of the Robert H Lurie Comprehensive Cancer Center (2020–present) and Simpson Querrey Center for Epigenetics (2018–present), with expertise in computational biology and genomics.

• Computational Biology
• Genomics
• Transcriptional Regulation
• +۳ مورد دیگر

Bethany A. Buck serves as Associate Professor of Chemistry and Adjunct Associate Professor of Biochemistry at the University of Utah, with additional affiliation as Associate Member of the Huntsman Cancer Institute (HCI) Cancer Center. Her research bridges structural biology, biophysics, and cancer epigenetics to investigate molecular mechanisms of gene regulation. Education: B.S., University of Wisconsin, Stevens Point Ph.D., University of Minnesota, Twin Cities Research Expertise: Dr. Buck's laboratory employs a multidisciplinary approach integrating structural biology, biophysics, biochemistry, and cellular biology to study protein-DNA interactions, with primary focus on methyl-CpG binding proteins (MBPs) that interpret DNA methylation signals. Her work elucidates how MBPs recognize methylated DNA sequences to trigger chromatin remodeling and transcriptional silencing in cancer development, utilizing parallel in vitro structural/biophysical and cellular genomic methodologies to investigate MBP:DNA complexes and protein interaction networks. Publication Trends: Analysis of her 2013-2024 publications reveals consistent focus on structural characterization of epigenetic regulators, evolving from foundational studies of zinc finger readers (2013-2018) toward integrated DNA damage response mechanisms (2021-2024). Recent work expands into G-quadruplex dynamics and peptide macrocyclization techniques while maintaining core emphasis on cancer epigenetics, demonstrating methodological diversification within nucleic acid biochemistry. Scientific Awards: No awards are documented in the provided materials. Academic Leadership: Dr. Buck mentors graduate students in the Biological Chemistry and Molecular Biology Ph.D. programs, directing laboratory research that combines X-ray crystallography, biophysical assays, and genomic approaches. Her work receives institutional support through HCI Cancer Center resources and departmental infrastructure. Research Infrastructure: The Buck laboratory operates within the University of Utah's bioscience ecosystem, leveraging core facilities for structural biology and genomics to advance understanding of epigenetic dysregulation in cancer, with current projects targeting therapeutic intervention points in MBP regulatory networks.

• Structural Biology
• Biophysics
• Cancer Epigenetics
• +۳ مورد دیگر

CHEN Wei is a Chair Professor at the Department of Biology, School of Life Sciences, Southern University of Science and Technology (SUSTech), Shenzhen, China. He holds a Ph.D. from the Max Planck Institute for Molecular Genetics (2006) and previously served as a Full Professor (W3) at the Max-Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin (2015-2016). Prior to joining SUSTech, he led research groups at prestigious German institutions, contributing to large-scale genome centers and the Berlin Institute of Health. Education : Ph.D. (2006, Max Planck Institute), M.S. (2002, Sichuan University), B.S. (1993, Xiamen University) His research focuses on systems biology and genomics, particularly post-transcriptional gene regulation mechanisms and their roles in human diseases. His lab integrates next-generation sequencing technologies with computational approaches to study non-coding RNA functions, alternative splicing, and chromatin dynamics. Key projects include CRISPR-based functional studies, 3D genome analysis, and RNA editing in neurological and metabolic disorders. Recent publications highlight his work in Drosophila developmental genomics, chloroplast translation control, and cancer biology. The 2025 study on spatiotemporal multi-omics in Drosophila and 2024 articles on MatK's role in tRNA splicing and CRISPR-activated transcriptional regulation exemplify his interdisciplinary approach. Earlier works (2023-2022) address immune cell trafficking, alternative polyadenylation, and chromatin remodeling in cancer metastasis. At SUSTech, he leads a team with 4 research assistant professors, 2 postdoctoral fellows, 3 research assistants, and 7 graduate students. His lab has secured significant funding from EU and German agencies (€7M+), though specific awards are not detailed in the provided text. Teaching responsibilities include General Biology and Principles of Cell Biology.

• Systems Biology
• Genomics
• Post-transcriptional Gene Regulation
• +۳ مورد دیگر

Ahmet Yildiz serves as Professor of Biochemistry, Biophysics and Structural Biology and of Physics at the University of California, Berkeley, leading an active research laboratory in Stanley Hall focused on the biophysical mechanisms of intracellular transport. Research interests center on motor protein dynamics, particularly dynein and kinesin function along cytoskeletal tracks. The Yildiz Laboratory employs integrated approaches including single-molecule fluorescence imaging, optical trapping, and cryo-electron microscopy to investigate how motors achieve processive movement, generate force in crowded cytoplasmic environments, and are regulated by adaptor proteins and microtubule-associated proteins (MAPs). Key projects examine dynein activation by Lis1/NudE, bidirectional transport reconstitution for mitochondrial cargo, and the "MAP code" hypothesis governing motor recruitment. Recent publications (2023-2025) demonstrate consistent focus on structural-mechanistic insights into dynein-dynactin complexes and regulatory mechanisms, with emerging connections to neurodegenerative disease pathways through neuronal transport studies. The work bridges quantitative biophysics with cellular physiology through advanced in vitro reconstitution techniques. The laboratory operates within UC Berkeley's collaborative research ecosystem, utilizing specialized facilities for high-resolution structural biology and single-molecule analysis to advance fundamental understanding of cellular organization principles.

• Motor Proteins
• Intracellular Transport
• Cytoskeletal Dynamics
• +۴ مورد دیگر

Julian Sale is a Professor at the University of Cambridge, leading the Vertebrate Mutagenesis Group at the MRC Laboratory of Molecular Biology (MRC-LMB). His research focuses on DNA replication mechanisms and mutagenesis, particularly how cells resolve replication stress caused by DNA damage or secondary structures like G-quadruplexes. Using vertebrate somatic cell genetics combined with biochemical and advanced imaging techniques, his lab investigates translesion synthesis (TLS), histone recycling during replication, and the molecular choreography at stalled replication forks. Key findings include TLS's dual role in mutagenesis and genome stability, as well as mechanisms for resolving non-B DNA structures during replication. The lab's recent publications highlight advancements in understanding replication origin efficiency, mutational landscapes, and structural DNA impediments. Collaborative studies with colleagues such as Murat, Guilbaud, and Lerner demonstrate interdisciplinary approaches integrating biophysics, genomics, and molecular biology.

• DNA Replication
• Translesion Synthesis (TLS)
• G-quadruplex Biology
• +۳ مورد دیگر

Yoseph Barash is an Associate Professor at the University of Pennsylvania, jointly appointed in the Perelman School of Medicine's Department of Genetics and the School of Engineering and Applied Science's Department of Computer and Information Science. He leads the BioCiphers Lab, integrating machine learning with experimental biology to decode RNA biogenesis and splicing regulation in human disease. Education: B.Sc. in Physics and Computer Science, Hebrew University Ph.D. in Machine Learning, Hebrew University (2006) His research spans Machine Learning , Computational Biology , and Bioinformatics , focusing on predictive models for RNA splicing and its role in diseases like cancer and neurological disorders. He pioneered the splicing code (Barash et al., Nature 2010) and extended it to genetic variations (Xiong et al., Science 2015). Recent publications emphasize RNA splicing variations in cancer, tool development (e.g., MAJIQ V3, MAJIQ-CLIN), and machine learning for drug discovery (e.g., trametinib sensitivity in AML). His work bridges computational innovation with wet-lab validation, enabling novel high-throughput assays. Scientific Awards: Lap-Chee Tsui Publication Award (2010) NSERC EWR Steacie Fellowship Canadian Institute for Advanced Research Fellowship He advises companies in RNA therapeutics and has licensed splicing quantification tools to Pfizer, GSK, and Biogen. His lab collaborates extensively, training students and postdocs in interdisciplinary approaches to RNA biology.

• Machine Learning
• Computational Biology
• Bioinformatics
• +۴ مورد دیگر

Dinshaw Patel is a Professor at the Structural Biology Program of Memorial Sloan Kettering Cancer Center (MSKCC), holding the Abby Rockefeller Mauzé Chair in Experimental Therapeutics. He has affiliations with Columbia University, The Rockefeller University, and Weill Cornell Medicine through collaborative research projects. PhD in Photochemistry, New York University Postdoctoral training in Biochemistry and Biophysics 17 years at AT&T Bell Laboratories Professor at Columbia University-Health Sciences His research focuses on structural biology of macromolecular recognition systems, particularly CRISPR-Cas surveillance complexes, cGAS-STING pathways, Structure Maintenance of Chromosomes (Smc5/6, MRX) complexes, and epigenetic regulation via histone/DNA modifications. His work spans RNA-mediated processes (siRNA/piRNA pathways), molecular chaperones, and riboswitches/ribozymes. Recent projects include structural characterization of bacterial antiphage defense systems (Lamassu, Kiwa), small molecule inhibitors targeting SARS-CoV-2 RNA capping machinery, and complexes involved in leukemias/lymphomas. Publications highlight structural elucidation of CRISPR-Cas systems using cryo-EM and x-ray crystallography, DNA repair mechanisms, and RNA-protein interaction dynamics. Key collaborations include Luciano Marraffini (Rockefeller), Xiaolan Zhao (MSKCC), and Thomas Tuschl (Rockefeller). National Academy of Sciences member AAAS member AT&T Bell Labs Distinguished Technical Staff Award New York University Distinguished Alumnus Award FEZANA Excellence in Profession Award Lifetime Achievement, American Association of Indian Scientists in Cancer Research Students and trainees benefit from his expertise in structural biology techniques (NMR, crystallography, cryo-EM), biochemical assays, and biophysical approaches. His lab participates in the Tri-Institutional PhD Program in Chemical Biology and maintains affiliations with multiple institutions including Beijing Advanced Innovation Center for Structural Biology and ETH Zürich.

• Structural Biology
• Biochemistry
• CRISPR-Cas Systems
• +۷ مورد دیگر

Tracy Brooks is the Chair and Associate Professor of Pharmaceutical Sciences at Binghamton University's School of Pharmacy and Pharmaceutical Sciences, holding the Menner Family Endowed Faculty Fellowship. She specializes in oncology and anti-cancer therapeutics, focusing on drug target development through DNA and protein interactions. Her research emphasizes G-quadruplex stabilization in oncogene promoters to regulate transcription, with applications in pancreatic, prostate, and breast cancers. Education: Bachelor of Science (BS) from the University of Rochester Doctor of Philosophy (PhD) from the University at Buffalo (SUNY) Research Interests: Tracy's work centers on developing novel therapies targeting oncogenes like KRAS and MYC. She explores G-quadruplex structures in promoter regions to inhibit cancer cell proliferation, leveraging small molecules and oligonucleotides. Her lab also investigates nucleic acid delivery systems and the role of epigenetic modifications (e.g., 5-hydroxymethylcytosine) in DNA structure stability. Recent Article Trends: Her publications (2020–2025) highlight advancements in G-quadruplex ligand design, antibody-drug conjugates (ADCs), and combinatorial therapies targeting KRAS/MYC pathways. Key themes include optimizing ADC stability, validating G-quadruplex-based approaches for pancreatic cancer, and exploring transcriptional control mechanisms. Awards: Inaugural Menner Family Endowed Faculty Fellow (2017) Advising & Grants: While specific grant details are not listed, her research has consistently addressed translational oncology challenges. She advises students on projects involving molecular pharmacology and drug delivery, emphasizing cross-disciplinary approaches. Labs & Teams: Her lab focuses on translational cancer research, collaborating with institutions like the University of Arizona and University of Mississippi on drug development and mechanistic studies.

• Oncology
• Anti-cancer therapeutics
• Drug target development
• +۳ مورد دیگر